Role of Vitamin K2 in Chronic Kidney Disease

PHASE4RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 15, 2023

Primary Completion Date

July 14, 2026

Study Completion Date

July 15, 2026

Conditions

Chronic Kidney Diseases

Interventions

DRUG

Placebo

Placebo match vitamin K2 capsules once per day.

DRUG

Vitamin K 2

Patients will be treated with vitamin K2 (menaquinone-7) 90 mcg/day.

Trial Locations (1)

RECRUITING

Faculty of Pharmacy Tanta University, Tanta

All Listed Sponsors

lead

Tanta University

OTHER